drugset / Trial / NCT00810108

Lopinavir/Ritonavir (Kaletra) PK in Children

NCT00810108

RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to compare the pharmacokinetics of lopinavir tablets administered to pediatric patients as either whole or crushed tablets. The study is a randomized,open-label, crossover study of pediatric subjects already taking lopinavir/ritonavir tablets as part of their clinical care. THe investigators hypothesize that lopinavir exposure in pediatric patients will be lower after taking a dose of the tablet formulation, crushed and mixed with pudding or yogurt, as compared to the exposure after taking a dose with tablets swallowed whole.

Timeline

Start
2006-06
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lopinavir Other / unclassified Oral
Background Ritonavir Other / unclassified Oral